Wall Street Experts
ver. ZuMIgo(08/25)
Apeloa Pharmaceutical Co.,Ltd
Rachunek Zysków i Strat
Przychody TTM (mln): 12 226
EBIT TTM (mln): 1 245
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
226 |
179 |
142 |
659 |
770 |
831 |
1,035 |
1,149 |
1,042 |
1,250 |
1,368 |
1,521 |
1,534 |
3,480 |
3,900 |
4,233 |
4,338 |
4,772 |
5,552 |
6,376 |
7,211 |
7,880 |
8,943 |
10,545 |
11,418 |
12,022 |
Przychód Δ r/r |
0.0% |
-20.8% |
-20.7% |
364.9% |
16.8% |
7.8% |
24.7% |
10.9% |
-9.3% |
20.1% |
9.4% |
11.2% |
0.9% |
126.8% |
12.1% |
8.5% |
2.5% |
10.0% |
16.3% |
14.9% |
13.1% |
9.3% |
13.5% |
17.9% |
8.3% |
5.3% |
Marża brutto |
17.1% |
12.4% |
7.8% |
22.5% |
20.6% |
19.2% |
19.5% |
20.3% |
18.8% |
19.1% |
21.9% |
21.0% |
19.4% |
23.2% |
22.6% |
26.0% |
27.4% |
27.8% |
30.8% |
31.9% |
32.4% |
28.0% |
26.5% |
23.9% |
23.9% |
23.8% |
EBIT (mln) |
9 |
5 |
-25 |
50 |
51 |
49 |
53 |
61 |
25 |
27 |
35 |
21 |
-11 |
144 |
185 |
343 |
202 |
274 |
336 |
491 |
644 |
970 |
1,119 |
1,012 |
1,082 |
1,212 |
EBIT Δ r/r |
0.0% |
-45.0% |
-612.5% |
-299.2% |
1.7% |
-4.1% |
8.8% |
15.9% |
-58.7% |
5.2% |
29.6% |
-38.7% |
-153.8% |
-1360.2% |
29.2% |
85.0% |
-41.0% |
35.2% |
22.7% |
46.1% |
31.3% |
50.5% |
15.4% |
-9.6% |
7.0% |
12.0% |
EBIT (%) |
3.9% |
2.7% |
-17.7% |
7.6% |
6.6% |
5.9% |
5.1% |
5.3% |
2.4% |
2.1% |
2.5% |
1.4% |
-0.7% |
4.1% |
4.8% |
8.1% |
4.7% |
5.7% |
6.0% |
7.7% |
8.9% |
12.3% |
12.5% |
9.6% |
9.5% |
10.1% |
Koszty finansowe (mln) |
3 |
6 |
9 |
16 |
13 |
18 |
24 |
34 |
38 |
35 |
36 |
38 |
40 |
108 |
82 |
80 |
66 |
62 |
62 |
42 |
30 |
16 |
36 |
59 |
47 |
36 |
EBITDA (mln) |
5 |
12 |
-13 |
95 |
97 |
104 |
120 |
148 |
123 |
136 |
170 |
167 |
162 |
493 |
541 |
736 |
650 |
755 |
759 |
871 |
1,052 |
1,309 |
1,580 |
1,560 |
1,641 |
1,810 |
EBITDA(%) |
2.1% |
6.8% |
-9.0% |
14.4% |
12.6% |
12.5% |
11.6% |
12.9% |
11.8% |
10.9% |
12.4% |
11.0% |
10.6% |
14.2% |
13.9% |
17.4% |
15.0% |
15.8% |
13.7% |
13.7% |
14.6% |
16.6% |
17.7% |
14.8% |
14.4% |
15.1% |
Podatek (mln) |
2 |
-1 |
1 |
17 |
13 |
11 |
5 |
10 |
3 |
1 |
5 |
7 |
1 |
34 |
45 |
50 |
39 |
72 |
83 |
92 |
80 |
144 |
159 |
23 |
149 |
172 |
Zysk Netto (mln) |
8 |
7 |
-26 |
32 |
34 |
36 |
44 |
52 |
30 |
29 |
34 |
24 |
8 |
137 |
167 |
322 |
208 |
263 |
257 |
371 |
553 |
817 |
956 |
989 |
1,055 |
1,031 |
Zysk netto Δ r/r |
0.0% |
-2.0% |
-446.0% |
-222.1% |
8.2% |
4.2% |
22.8% |
18.7% |
-41.4% |
-4.5% |
17.3% |
-30.2% |
-65.3% |
1562.3% |
22.0% |
92.5% |
-35.4% |
26.3% |
-2.4% |
44.4% |
49.3% |
47.6% |
17.0% |
3.5% |
6.7% |
-2.3% |
Zysk netto (%) |
3.4% |
4.2% |
-18.2% |
4.8% |
4.4% |
4.3% |
4.2% |
4.5% |
2.9% |
2.3% |
2.5% |
1.6% |
0.5% |
3.9% |
4.3% |
7.6% |
4.8% |
5.5% |
4.6% |
5.8% |
7.7% |
10.4% |
10.7% |
9.4% |
9.2% |
8.6% |
EPS |
0.0107 |
-0.0048 |
-0.0408 |
0.0445 |
0.0481 |
0.0501 |
0.0616 |
0.0938 |
0.048 |
0.0435 |
0.0511 |
0.0346 |
0.0777 |
0.28 |
0.21 |
0.3 |
0.18 |
0.23 |
0.22 |
0.31 |
0.47 |
0.69 |
0.81 |
0.85 |
0.9 |
0.89 |
EPS (rozwodnione) |
0.0107 |
-0.0048 |
-0.0408 |
0.0445 |
0.0481 |
0.0501 |
0.0616 |
0.0938 |
0.048 |
0.0435 |
0.0511 |
0.0346 |
0.0777 |
0.28 |
0.21 |
0.3 |
0.18 |
0.23 |
0.22 |
0.31 |
0.47 |
0.69 |
0.81 |
0.85 |
0.9 |
0.89 |
Ilośc akcji (mln) |
635 |
635 |
635 |
635 |
635 |
635 |
635 |
568 |
635 |
667 |
667 |
687 |
973 |
487 |
797 |
1,074 |
1,147 |
1,143 |
1,150 |
1,179 |
1,179 |
1,179 |
1,179 |
1,169 |
1,169 |
1,158 |
Ważona ilośc akcji (mln) |
635 |
635 |
635 |
635 |
635 |
635 |
635 |
568 |
635 |
667 |
667 |
687 |
973 |
487 |
797 |
1,074 |
1,157 |
1,143 |
1,150 |
1,179 |
1,179 |
1,179 |
1,179 |
1,169 |
1,169 |
1,158 |
Waluta |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |
CNY |